Education
About Us
Working with TipRanks
Follow Us
Profound Medical (TSE:PRN)
TSX:PRN
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 22.49M | $ 10.68M | $ 7.20M | $ 6.68M | $ 6.87M |
| Gross Profit | $ 15.92M | $ 7.04M | $ 4.38M | $ 3.02M | $ 2.95M |
| Operating Income | $ -57.64M | $ -33.06M | $ -28.62M | $ -29.60M | $ -30.29M |
| EBITDA | $ -56.86M | $ -32.13M | $ -27.00M | $ -34.63M | $ -28.65M |
| Net Income | $ -59.48M | $ -27.82M | $ -28.57M | $ -28.67M | $ -30.70M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 81.87M | $ 54.91M | $ 26.21M | $ 46.52M | $ 67.15M |
| Total Assets | $ 193.10M | $ 70.23M | $ 43.91M | $ 64.42M | $ 86.78M |
| Total Debt | $ 6.46M | $ 5.12M | $ 7.87M | $ 8.23M | $ 1.38M |
| Net Debt | $ -75.41M | $ -49.79M | $ -18.35M | $ -38.29M | $ -65.78M |
| Total Liabilities | $ 102.04M | $ 9.81M | $ 12.73M | $ 12.42M | $ 6.16M |
| Stockholders' Equity | $ 91.06M | $ 60.42M | $ 31.18M | $ 52.00M | $ 80.62M |
| Cash Flow | |||||
| Free Cash Flow | $ -53.63M | $ -23.45M | $ -22.30M | $ -25.80M | $ -22.95M |
| Operating Cash Flow | $ -53.39M | $ -23.45M | $ -22.30M | $ -25.80M | $ -22.36M |
| Investing Cash Flow | $ -338.14K | $ 0.00 | $ 0.00 | $ 0.00 | $ -593.00K |
| Financing Cash Flow | $ 57.48M | $ 54.70M | $ 1.46M | $ 7.03M | $ 5.95M |